OFI Advisors’s Bristol-Myers Squibb BMY Stock Holding History

OFI Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.38M	Sell	23,251 -1,036	-4%	-$65.7K	0.09%	231
2015 Q2	$1.62M	Buy	24,287 +3,674	+18%	+$242K	0.1%	217
2015 Q1	$1.33M	Sell	20,613 -1,319	-6%	-$82.6K	0.08%	271
2014 Q4	$1.29M	Sell	21,932 -2,936	-12%	-$166K	0.08%	247
2014 Q3	$1.27M	Sell	24,868 -1,353	-5%	-$67.6K	0.09%	214
2014 Q2	$1.27M	Buy	26,221 +4,809	+22%	+$237K	0.09%	218
2014 Q1	$1.11M	Sell	21,412 -56	-0.3%	-$2.98K	0.09%	238
2013 Q4	$1.14M	Buy	21,468 +415	+2%	+$21.1K	0.09%	214
2013 Q3	$974K	Sell	21,053 -222	-1%	-$9.74K	0.09%	208
2013 Q2	$951K	Buy	+21,275	New	+$924K	0.1%	196

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OFI Advisors's BMY Position: Q3 2015 in Review

OFI Advisors reduced its Bristol-Myers Squibb (BMY) stake by 4.3% in Q3 2015, selling an estimated $65.7K and leaving 23,251 shares worth $1.38M. The position accounts for 0.09% of the portfolio, ranked #231.

OFI Advisors first reported a position in BMY in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.62M in Q2 2015. 1,453 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

OFI Advisors held 23,251 shares of Bristol-Myers Squibb worth $1.38M as of Q3 2015.
OFI Advisors sold 1,036 Bristol-Myers Squibb shares in Q3 2015, an estimated $65.7K.
Bristol-Myers Squibb made up 0.09% of OFI Advisors's portfolio in Q3 2015, its #231 holding.
OFI Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Bristol-Myers Squibb position peaked at $1.62M in Q2 2015.
1,453 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.